தேசிய மருந்தியல் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய மருந்தியல் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய மருந்தியல் மையம் Today - Breaking & Trending Today

Sinopharm vaccine not to be given to immune-compromised persons: Drap


National
February 17, 2021
LAHORE: The Drug Regulatory Authority of Pakistan (Drap) has declared that Sinopharm vaccine against COVID-19 should not be administered to immune-compromised individuals.
The Drap, Ministry of National Health Services, Regulations and Coordination, directed that use of the vaccine in patients with comorbidities should be based on a favourable benefit/risk ratio.
The Sinopharm vaccine, manufactured by M/s Beijing Institute of Biological Products Co, Ltd, China, has been approved for grant of registration of SARS-CoV-2 Vaccine (Vero Cell) for emergency use authorisation for active immunisation of individuals between 18 to 60 years of age. The Registration Board, however, noted that the vaccine has already been granted market authorisations and emergency use authorisations in China, UAE and Bahrain. ....

Institute Of Biological Products Co Ltd , Pharmacy Services Division Drap , Drug Regulatory Authority Of Pakistan Drap , Ministry Of National Health Services , National Pharmacovigilance Centre , Gamaleya National Center , Drug Regulatory Authority , National Health Services , Beijing Institute , Vero Cell , Registration Board , Clinical Trials , Post Marketing , Adverse Events Following Immunisation , Emergency Use Authorisation , Russian Sputnik V , Sino Pharm , நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் , அமைச்சகம் ஆஃப் தேசிய ஆரோக்கியம் சேவைகள் , தேசிய மருந்தியல் மையம் , மருந்து ஒழுங்குமுறை அதிகாரம் , தேசிய ஆரோக்கியம் சேவைகள் , பெய்ஜிங் நிறுவனம் , வெரோ செல் , பதிவு பலகை , மருத்துவ சோதனைகள் ,

Russian vaccine gets emergency use authorisation - Pakistan


A shipment of doses of the Sputnik V (Gam-Covid-Vac) vaccine against the coronavirus is seen after arriving at Ezeiza International Airport, in Buenos Aires, Argentina on Jan 28. Reuters/File
ISLAMABAD: While 1,286 more people tested positive for Covid-19 in a single day on Saturday, the Drug Regulatory Authority of Pakistan (Drap) issued an Emergency Use Authorisation (EUA) to Russian Covid-19 vaccine Sputnik V.
After the Drap’s EUA, now both the government and the private sector can procure three medicines i.e. British vaccine Oxford AstraZeneca, Chinese vaccine Sinopharm and Russian Sputnik V.
According to a document available with
Dawn, Sputnik V has been manufactured by the “National Research Centre for Epidemiology and Microbiology” of the Ministry of Health of the Russian Federation. ....

Ali Gohar , North West Frontier , United Kingdom , Russian Federation , Oxford Astrazeneca , Asad Umar , Drug Regulatory Authority Of Pakistan Drap , National Research Centre For Epidemiology , Ali Gohar Pharmaceuticals , Operation Centre , Ministry Of National Health Services , National Pharmacovigilance Centre , Drug Regulatory Authority , Emergency Use Authorisation , Russian Sputnik , Research Centre , Federal Minister , Special Initiatives , Saturday Asad Umar , National Health Services , National Command , Corona Virus , அலி கோஹர் , வடக்கு மேற்கு எல்லை , ஒன்றுபட்டது கிஂக்டம் , ரஷ்ய கூட்டமைப்பு ,